Highlights
Fuente:
Wiley Open Access
Guardado en:
| Formato: | Artículo Open Access |
|---|---|
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Highlights
Publicado: (2024)
Publicado: (2024)
Highlights
Publicado: (2024)
Publicado: (2024)
Highlights
Publicado: (2024)
Publicado: (2024)
Highlighted Articles
Publicado: (2024)
Publicado: (2024)
Highlighted Articles
Publicado: (2024)
Publicado: (2024)
Highlighted Articles
Publicado: (2024)
Publicado: (2024)
Highlighted Articles
Publicado: (2024)
Publicado: (2024)
Highlighted Articles
Publicado: (2025)
Publicado: (2025)
Highlighted Articles
Publicado: (2025)
Publicado: (2025)
Highlighted Articles
Publicado: (2025)
Publicado: (2025)
Infection Risk Associated with High‐Efficacy Disease‐Modifying Agents in Multiple Sclerosis: A Retrospective Cohort Study
por: Jieni Li, et al.
Publicado: (2024)
por: Jieni Li, et al.
Publicado: (2024)
Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome‐Wide Investigation of Abnormal Dreams on Varenicline
por: Meghan J. Chenoweth, et al.
Publicado: (2024)
por: Meghan J. Chenoweth, et al.
Publicado: (2024)
Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
por: Mohamed Elmeliegy, et al.
Publicado: (2024)
por: Mohamed Elmeliegy, et al.
Publicado: (2024)
Optimizing Clinical Translation of Bispecific T‐cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model
por: Xiaozhi Liao, et al.
Publicado: (2024)
por: Xiaozhi Liao, et al.
Publicado: (2024)
Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.gov
por: Lars Masanneck, et al.
Publicado: (2024)
por: Lars Masanneck, et al.
Publicado: (2024)
Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression
por: Ruud van der Veen, et al.
Publicado: (2024)
por: Ruud van der Veen, et al.
Publicado: (2024)
Correction to “Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals”
Publicado: (2024)
Publicado: (2024)
Identifying Drug–Drug Interactions in Spontaneous Reports Utilizing Signal Detection and Biological Plausibility Aspects
por: Elpida Kontsioti, et al.
Publicado: (2024)
por: Elpida Kontsioti, et al.
Publicado: (2024)
Pathway‐Based Similarity Measurement to Quantify Transcriptomics Similarity Between Human Tissues and Preclinical Models
por: Paarth Parekh, et al.
Publicado: (2024)
por: Paarth Parekh, et al.
Publicado: (2024)
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
por: Caroline Marra, et al.
Publicado: (2024)
por: Caroline Marra, et al.
Publicado: (2024)
Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment
por: Raj Vuppalanchi, et al.
Publicado: (2024)
por: Raj Vuppalanchi, et al.
Publicado: (2024)
Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products
por: Magdi Elsallab, et al.
Publicado: (2024)
por: Magdi Elsallab, et al.
Publicado: (2024)
Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease
por: Pamela Navarro‐Gonzales, et al.
Publicado: (2024)
por: Pamela Navarro‐Gonzales, et al.
Publicado: (2024)
Corrections to “Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions”
Publicado: (2024)
Publicado: (2024)
Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
por: Qi Liu, et al.
Publicado: (2024)
por: Qi Liu, et al.
Publicado: (2024)
In this Issue
Publicado: (2024)
Publicado: (2024)
New Horizons of Model Informed Drug Development in Rare Diseases Drug Development
por: Amitava Mitra, et al.
Publicado: (2024)
por: Amitava Mitra, et al.
Publicado: (2024)
Rare Diseases Linked to Mutations in Vitamin Transporters Expressed in the Human Blood–Brain Barrier
por: Sook Wah Yee, et al.
Publicado: (2024)
por: Sook Wah Yee, et al.
Publicado: (2024)
Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
por: Peter N. Morcos, et al.
Publicado: (2024)
por: Peter N. Morcos, et al.
Publicado: (2024)
Transcriptomic Profiles Associated with Experimental Placebo Effects in Chronic Pain
por: Luana Colloca, et al.
Publicado: (2024)
por: Luana Colloca, et al.
Publicado: (2024)
Application and Quality of Model‐Based Meta‐Analysis in Pharmaceutical Research: A Systematic Cross‐Sectional Analysis and Practical Considerations
por: Zhirong Yang, et al.
Publicado: (2024)
por: Zhirong Yang, et al.
Publicado: (2024)
ASCPT News
Publicado: (2024)
Publicado: (2024)
In This Issue
Publicado: (2024)
Publicado: (2024)
Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation
por: Yoo Jin Jang, et al.
Publicado: (2024)
por: Yoo Jin Jang, et al.
Publicado: (2024)
Trust in the Food and Drug Administration: A National Survey Study
por: William B. Feldman, et al.
Publicado: (2024)
por: William B. Feldman, et al.
Publicado: (2024)
The Future of Machine Learning Within Target Identification: Causality, Reversibility, and Druggability
por: Jake P. Taylor‐King, et al.
Publicado: (2024)
por: Jake P. Taylor‐King, et al.
Publicado: (2024)
The Use of Real‐World Evidence for Regulatory Decisions in China
por: Jiayue Xu, et al.
Publicado: (2024)
por: Jiayue Xu, et al.
Publicado: (2024)
PharmVar GeneFocus: CYP4F2
por: Pablo Zubiaur, et al.
Publicado: (2024)
por: Pablo Zubiaur, et al.
Publicado: (2024)
Questioning Conclusions and Statements on the German HTA System: A Critical Perspective
por: Jörg Tomeczkowski, et al.
Publicado: (2024)
por: Jörg Tomeczkowski, et al.
Publicado: (2024)
Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes
por: Terence H.W. Ching, et al.
Publicado: (2024)
por: Terence H.W. Ching, et al.
Publicado: (2024)
Ejemplares similares
-
Highlights
Publicado: (2024) -
Highlights
Publicado: (2024) -
Highlights
Publicado: (2024) -
Highlighted Articles
Publicado: (2024) -
Highlighted Articles
Publicado: (2024)